Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting - Bouman, HJ; Harmsze, AM; van Werkum, JW (Heart, 2011)
DOI:10.1136/hrt.2010.220509.